Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with ...

More than 6 million patients in the United States receive long-term anticoagulation therapy for the prevention of thromboembolism due to atrial fibrillation, placement of a mechanical heart-valve ...

High-voltage electrical pulses to the upper region of the small intestine in a minimally invasive procedure can significantly improve type 2 diabetes, researchers reported at the Digestive Disease ...